Related Experiment Videos
[Congenital hypo(a)fibrinogenemia/congenital dysfibrinogenemia]
1Department of Transfusion Medicine, Nagoya University Hospital.
Ryoikibetsu Shokogun Shirizu
|December 2, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
Factor IX inhibition and epitope localization of factor IX inhibitor antibodies in haemophilia B patients with anaphylactoid reactions.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics.
Haemophilia : the official journal of the World Federation of Hemophilia·2013
Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd report.
Haemophilia : the official journal of the World Federation of Hemophilia·2012
An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
Haemophilia : the official journal of the World Federation of Hemophilia·2011
Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trial.
Haemophilia : the official journal of the World Federation of Hemophilia·2011
Does Tranexamic acid fix all bleeding in surgery?
Journal of the National Medical Association·2026
Pharmacokinetics, Elimination and Dialyzability of HRS-9231 in Patients with Varying Degrees of Renal Impairment.
Clinical pharmacokinetics·2026